Celluminova is a brand that specializes in developing new tools for stem cell research, with a specific focus on cancer stem cells. Their innovative product, GlioStem, is a patented biomarker that allows for live stem cell detection and visualization. Unlike existing methods, GlioStem is able to specifically identify glioma stem cells (GSCs), which are resistant to traditional cancer treatments.

GlioStem is administered onto the tissue or cell culture being investigated using a pipette, and within minutes, the GSCs emit green light under illumination. Extensive in vitro studies have verified GlioStem's high luminescence specificity for GSCs, allowing for efficient separation of GSCs from other glioma cells. The ultimate goal of Celluminova is to enable fluorescence-assisted surgery by providing near-instant feedback from live microscopy observations of GSCs, leading to more accurate tumor resections.

Their vision is to have their products used in clinical labs and surgery rooms worldwide, contributing to advancements in life science and improving clinical outcomes. To learn more or contact Celluminova, visit their website or reach out to their provided contact information